Compare RVSN & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RVSN | QNRX |
|---|---|---|
| Founded | 2016 | 2018 |
| Country | Israel | United States |
| Employees | 47 | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9M | 11.6M |
| IPO Year | N/A | 2023 |
| Metric | RVSN | QNRX |
|---|---|---|
| Price | $4.88 | $4.90 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 19.2K | ★ 23.1K |
| Earning Date | 03-31-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $860.32 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.17 | $4.80 |
| 52 Week High | $9.39 | $41.80 |
| Indicator | RVSN | QNRX |
|---|---|---|
| Relative Strength Index (RSI) | 21.48 | 29.59 |
| Support Level | $0.31 | N/A |
| Resistance Level | $9.07 | $6.84 |
| Average True Range (ATR) | 0.38 | 0.43 |
| MACD | -0.20 | -0.10 |
| Stochastic Oscillator | 6.35 | 8.57 |
Rail Vision Ltd is an early commercialization stage technology company focused on railway safety systems using AI-integrated sensing systems. The company develops and commercializes proprietary, multi-spectral electro-optic platforms that provide extended-range situational awareness and real-time hazard detection. Using machine learning algorithms to identify and classify obstacles, the company's technology enhances safety, improves operational efficiency, and supports continuity across deployments.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.